Co-transplantation of fetal lateral ganglionic eminence and ventral mesencephalon can augment function and development of intrastriatal transplants

Experimental Neurology

Volumn 145, Issue 1, 1997, Pages 214-227

  Costantini, Lauren C ^a   Snyder Keller, Abigail ^a  

^a UNIVERSITY AT ALBANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ARTICLE; BRAIN MATURATION; CELL SURVIVAL; CELL TRANSPLANTATION; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; DOPAMINERGIC NERVE CELL; EMBRYONAL TISSUE; MESENCEPHALON; NONHUMAN; PRIORITY JOURNAL; RAT; REINNERVATION;

EID: 0031148851     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1997.6477     Document Type: Article

References (68)

1. Abercrombie M. Estimation of nuclear populations from microtome sections. Anat. Rec. 94:1946;239-247.
2. Abrous D., Shaltot A., Torres E., Dunnett S. Dopamine-rich grafts into the neostriatum and/or nucleus accumbens: Effects on drug-induced behaviors and skilled paw reaching. Neuroscience. 53:1993;187-197.
3. Aronica E., Costantini L., Snyder-Keller A. Reciprocal influences of nigral cells and striatal patch neurons in dissociated co-cultures. J. Neurosci. Res. 44:1996;540-550.
4. Beck K., Knusel B., Hefti F. The nature of the trophic action of BDNF, IGF-1, and bFGF on mesencephalic dopaminergic neurons developing in culture. Neuroscience. 52:1993;855-966.
5. Bjorklund A., Campbell K., Sirinathsinghji D., Fricker R., Dunnett S. Functional capacity of striatal transplants in the rat Huntington model. Functional Neural Transplantation. 1994;Raven Press, New York. p. 157-195.
6. Bjorklund A., Lindvall O. Catecholaminergic brain stem regulatory systems. Bloom F. E. Handbook of Physiology: The Nervous System. Intrinsic Regulatory Systems in the Brain. 1986;155-235 Am. Physiol. Soc. Baltimore.
7. Bjorklund A., Lindvall O., Isacson O., Brundin P., Wictorin K., Strecker R., Clarke D., Dunnett S. Mechanisms of action of intracerebral neural implants: Studies on nigral and striatal grafts to the lesioned striatum. Trends Neurosci. 10:1987;509-516.
8. Bolam J., Freund T., Bjorklund A., Dunnett S., Smith A. Synaptic input and local output of dopaminergic neurons in grafts that functionally reinnervate the host striatum. Exp. Brain Res. 68:1987;131.
9. Brundin P., Isacson O., Bjorklund A. Monitoring of cell viability in suspensions of embryonic CNS tissue and its use as a criterion for intracerebral graft survival. Brain Res. 331:1985;251-259.
10. Brundin P., Isacson O., Gage F., Bjorklund A. Intrastriatal grafting of dopamine-containing neuronal cell suspensions: Effects of mixing with target or non-target cells. Dev. Brain Res. 24:1986;77-84.
11. Brundin P., Bjorklund A. Survival, growth, and function of dopaminergic neurons grafted to the brain. Prog. Brain Res. 71:1987;293-308.
12. Campbell K., Kalen P., Wictorin K., Lundberg C., Mandel R., Bjorklund A. Characterization of GABA release from intrastriatal striatal transplants: Dependence on host-derived afferents. Neuroscience. 53:1993;403-415.
13. Campbell K., Bjorklund A. Neurotransmitter-related gene expression in intrastriatal striatal transplants. III. Regulation by host cortical and dopaminergic afferents. Mol. Brain Res. 29:1995;273-284.
14. Cenci M., Kalen P., Mandel R., Wictorin K., Bjorklund A. Dopaminergic transplants normalize amphetamine- and apomorphine-induced FOS expression in the hydroxydopamine-lesioned striatum. Neuroscience. 46:1992;943-957.
15. Clarke D., Brundin P., Strecker R., Nilsson O., Bjorklund A., Lindvall O. Human fetal dopamine neurons grafted in a rat model of Parkinson's disease: Ultrastructural evidence for synapse formation using tyrosine hydroxylase immunocytochemistry. Exp. Brain Res. 73:1988;115-126.
16. Costantini L., Vozza B., Snyder-Keller A. Enhanced efficacy of nigral-striatal cotransplants in bilaterally dopamine-depleted rats: An anatomical and behavioral analysis. Exp. Neurol. 127:1994;219-231.
17. Costantini L., Feinstein S., Radeke M., Snyder-Keller A. TrkB receptors localize to patches in developing striatum. Soc. Neurosci. Abstr. 22:1996;1479.
18. Dal Toso R., Giorgi O., Soranzo C., Kirschner G., Ferrari G., Favaron M., Benvegnu D., Presti D., Vicini S., Toffano G., Azzone G., Leon A. Development and survival of neurons in dissociated fetal mesencephalic serum-free cell cultures: I. Effects of cell density and of an adult mammalian striatal-derived neuronotrophic factor (SDNF). J. Neurosci. 8:1988;733-745.
19. Deacon T., Pakzaban P., Isacson O. The lateral ganglionic eminence is the origin of cells committed to striatal phenotype: Neural transplantation and developmental evidence. Brain Res. 668:1994;211-219.
20. BeBeaurepaire R., Freed W. Embryonic substantia nigra grafts innervate embryonic striatal co-grafts in preference to mature host striatum. Exp. Neurol. 95:1987;448-454.
21. Denis-Donini S., Glowinski J., Prochiantz A. Specific influence of striatal target neurons on the in vitro outgrowth of mesencephalic dopaminergic neurites: A morphological quantitative study. J. Neurosci. 3:1983;2292-2299.
22. Di Porzio U., Daguet J., Glowinski J., Prochiantz A. Effect of striatal cells on in vitro maturation of mesencephalic dopaminergic neurons grown in serum-free conditions. Nature. 288:1980;370-373.
23. Dong J., Detta A., Bakker M., Hitchcock E. Direct interaction with target-derived glia enhances survival but not differentiation of human fetal mesencephalic dopaminergic neurons. Neuroscience. 56:1993;53-60.
24. Doucet G., Brundin P., Descarries L., Bjorklund A. Effect of prior dopamine denervation on survival and fiber outgrowth from intrastriatal fetal mesencephalic grafts. Eur. J. Neurosci. 2:1990;279-290.
25. Doucet G., Murata Y., Brundin P., Bosler O., Mons N., Geffard M., Quimet C., Bjorklund A. Host afferents into intrastriatal transplants of fetal ventral mesencephalon. Exp. Neurol. 106:1989;1-19.
26. Dunnett S., Wishaw I., Rogers D., Jones G. Dopamine-rich grafts ameliorate whole body motor asymmetry and sensory neglect but not independent limb use in rats with 6-hydroxydopamine lesions. Brain Res. 415:1987;63-78.
27. Dunnett S., Rogers D., Richards S. Nigrostriatal reconstruction after 6-OHDA lesions in rats: Combination of dopamine-rich nigral grafts and nigrostriatal "bridge" grafts. Exp. Brain Res. 75:1989;523-535.
28. Elsworth J., Sladek J., Taylor J., Collier T., Redmond D., Roth R. Early gestational mesencephalon grafts but not later gestational mesencephalon, cerebellum, or sham grafts, increase dopamine in caudate nucleus of MPTP-treated monkeys. Neuroscience. 72:1996;477-484.
29. Freeman T., Olanow C., Hauser R., Nauert G., Smith D., Borlongan C., Sanberg P., Holt D., Kordower J., Vingerhoet F., Snow B., Calne D., Gauger L. Bilateral fetal nigral transplantation into the postcommisural putamen in Parkinson's disease. Ann. Neurol. 38:1995;379-388.
30. Graybiel A., Mortally R., Robertson H. Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome-matrix compartments and limbic subdivisions of the striatum. Proc. Natl. Acad. Sci. USA. 87:1990;6912-6916.
31. Hantraye P., Riche D., Maziere M., Isacson O. Intrastriatal transplantation of cross-species fetal striatal cells reduces abnormal movements in a primate model of Huntington's disease. Proc. Natl. Acad. Sci. USA. 89:1992;4187-4191.
32. Hemmendinger L., Garber B., Hoffman P., Heller A. Target neuron-specific process formation by embryonic mesencephalic dopamine neurons in vitro. Proc. Natl. Acad. Sci. USA. 78:1981;1264-1268.
33. Hornykeiwicz O. Parkinson's disease: From brain homogenate to treatment. Fed. Proc. 32:1973;183-189.
34. Isacson O., Dawbarn D., Brundin P., Gage F., Meson P., Bjorklund A. Neural grafting in a rat model of Huntington's disease: Striosomal-like organization of striatal grafts as revealed by acetylcholinesterase histochemistry, immunocytochemistry, and receptor autoradiography. Neuroscience. 22:1987;481-497.
35. Jaeger C. Axon terminal clustering in nigrostriatal double grafts. Dev. Brain Res. 24:1986;309-314.
36. Kordower J., Freeman T., Snow B., Vingerhoets F., Muffson E., Sanberg P., Hauser R., Smith D., Nauert G., Perl D., Olanow C. Neuropathological evidence of graft survival and striatal reinnervation after transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N. England J. Med. 332:1995;1118-1124.
37. Kordower J., Rosenstein J., Collier T., Burke M., Chen E., Li J., Martel L., Levey A., Mufson E., Freeman T., Olanow C. Functional fetal nigral grafts in a patient with Parkinson's disease: Chemoanatomic, ultrastructural, and metabolic studies. J. Comp. Neurol. 370:1996;203-230.
38. Labandiera-Garcia J., Tobio J., Guerra M. Comparison between normal developing striatum and developing striatal grafts using drug-induced Fos expression and neuron-specific enolase immunohistochemistry. Neuroscience. 60:1994;399-415.
39. Labandiera-Garcia J., Wictorin K., Cunningham E., Bjorklund A. Development of intrastriatal striatal grafts and their afferent innervation from the host. Neuroscience. 42:1991;407-426.
40. Langeveld C., Jongenelen C., Schepens E., Stoof J., Bast A., Drukarch B. Cultured rat striatal and cortical astrocytes protect mesencephalic dopaminergic neurons against hydrogen peroxide toxicity independent of their effect on neuronal development. Neurosci. Lett. 192:1995;13-16.
41. Lin L., Doherty D., Lile J., Bektesh S., Collins F. (GDNF) a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science. 260:1993;1130-1132.
42. Lindvall O., Brundin P., Widner H., Rehncrona S., Gustavii B., Frackowiak R., Leenders K., Sawle G., Rothwell J., Marsden C., Bjorklund A. Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science. 242:1990;574-577.
43. Liu F., Dunnett S., Robertson H., Graybiel A. Intrastriatal grafts derived from fetal striatal primordia. III. Induction of modular patterns of Fos-like immunoreactivity by cocaine. Exp. Brain Res. 85:1991;501-506.
44. Mandel R., Wictorin K., Cenci M., Bjorklund A. Fos expression in intrastriatal striatal grafts: Regulation by host dopaminergic afferents. Brain Res. 583:1992;207-215.
45. Nakao N., Odin P., Brundin P. Selective sub-dissection of the striatal primordium for cultures affects the yield of DARPP-32 containing neurons. NeuroReport. 5:1994;1081-1084.
46. Nikkhah G., Odin P., Smits A., Tingstrom A., Othberg A., Brundin P., Funa K., Lindvall O. Platelet-derived growth factor promotes survival of rat and human mesencephalic dopaminergic neurons in culture. Exp. Brain Res. 92:1993;516-523.
47. Nikkhah G., Cunningham M., Jodicke A., Knappe U., Bjorklund A. Improved graft survival and striatal reinnervation by microtransplantation of fetal nigral cell suspensions in the rat Parkinson model. Brain Res. 633:1994;133-143.
48. Ostergaard K., Schou J., Zimmer J. Rat ventral mesencephalon grown as organotypic slice cultures and co-cultured with striatum, hippocampus, and cerebellum. Exp. Brain Res. 82:1990;547-565.
49. Pakzaban P., Deacon T., Burns L., Isacson O. Increased proportion of acetylcholinesterase-rich zones and improved morphological integration into host striatum of fetal grafts derived from the lateral but not the medial ganglionic eminence. Exp. Brain Res. 97:1993;13-22.
50. Prochiantz A., DiPorzio U., Kato A., Berger B., Glowinski J. In vitro maturation of mesencephalic dopaminergic neurons from mouse embryos is enhanced in presence of their striatal target cells. Proc. Natl. Acad. Sci. USA. 76:1979;5387-5391.
51. Prochiantz A., Daguet M., Herbert A., Glowinski J. Specific stimulation of in vivo maturation of mesencephalic dopaminergic neurons by striatal membranes. Nature. 293:1981;570-572.
52. Rioux L., Gaudin D., Bui L., Gregoire L., DiPaolo T., Bedard P. Correlation of functional recovery after a 6-hydroxydopamine lesion with survival of grafted fetal neurons and release of dopamine in the striatum of the rat. Neuroscience. 40:1991;123-131.
53. Sagar S., Sharp F., Curran T. Expression of c-fos protein in brain: Metabolic mapping at the cellular level. Science. 240:1988;1328-1331.
54. Shalaby I., Hoffmann P., Heller A. Release of dopamine from mesencephalic neurons in aggregate cultures: Influence of target and non-target cells. Brain Res. 307:1984;347-350.
55. Sladek J., Collier T., Elsworth J., Taylor J., Roth R., Redmond D. Can graft-derived neurotrophic activity be used to direct axonal outgrowth of grafted dopamine neurons for circuit reconstruction in primates. Exp. Neurol. 124:1993;134-139.
56. Snyder-Keller A., Carder R., Lund R. Development of dopamine innervation and turning behavior in dopamine-depleted infant rats receiving unilateral transplants. Neuroscience. 30:1989;779-794.
57. Snyder-Keller A. Striatal c-fos induction by drugs and stress in neonatally dopamine-depleted rats given nigral transplants: Importance of NMDA activation and relevance to sensitization phenomena. Exp. Neurol. 114:1991;155-165.
58. Snyder-Keller A., Costantini L. Glutamate receptor subtypes localize to patches in the developing striatum. Dev. Brain Res. 94:1996;246-250.
59. Sommer W., Bjelke B., Gante D., Fuxe K. Antisense oligonucleotide to c-fos induces ipsilateral rotational behavior tod. NeuroReport. 5:1993;277-220.
60. Spencer D., Robbins R., Naftolin F., Phil D., Marek J., Vollmer T., Leranth C., Roth R., Price L., Gjedde A., Bunney B., Sass K., Elsworth J., Kier L., Makuch R., Hoffer P., Redmond E. Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease. N. Eng. J. Med. 327:1992;1541-1548.
61. Strecker R., Sharp T., Brundin P., Zetterstrom T., Ungerstedt U., Bjorklund A. Autoregulation of dopamine release and metabolism by intrastriatal nigral grafts as revealed by intracerebral dialysis. Neuroscience. 22:1987;169-178.
62. Takeshima T., Shimoda K., Sauve Y., Commissiong J. Astrocyte-dependent and -independent phases of the development and survival of rat embryonic day 14 mesencephalic, dopaminergic neurons in culture. Neuroscience. 60:1994;809-823.
63. Tomozawa Y., Appel S. Soluble striatal extracts enhance development of mesencephalic dopaminergic neurons in vitro. Brain Res. 399:1986;111-124.
64. van der Kooy D., Fishell G. Neuronal birthdate underlies the development of striatal compartments. Brain Res. 401:1987;155-161.
65. Wictorin K. Anatomy and connectivity of intrastriatal striatal transplants. Prog. Neurobiol. 38:1992;611-639.
66. Wictorin K., Ouimet C., Bjorklund A. Intrinsic organization and connectivity of intrastriatal striatal transplants in rats as revealed by DARPP-32 immunohistochemistry. Eur. J. Neurosci. 1:1989;690-701.
67. Yurek D., Collier T., Sladek J. Embryonic mesencephalic and striatal co-grafts: Development of grafted dopamine neurons and functional recovery. Exp. Neurol. 109:1990;191-199.
68. Zhou F., Buchwald N. Connectivities of the striatal grafts in adult rat brain: a rich afference and scant striatonigral efference. Brain Res. 504:1989;15-30.